Ovid Therapeutics Aktie
WKN DE: A2DQ8S / ISIN: US6904691010
|
02.12.2025 13:45:35
|
Ovid Therapeutics Names Petra Kaufmann Chief Medical Officer
(RTTNews) - Ovid Therapeutics Inc. (OVID) on Tuesday announced the appointment of Petra Kaufmann as its chief medical officer.
Kaufmann brings extensive experience from both the biopharmaceutical industry and the U.S. National Institutes of Health, where she previously led national rare-disease research initiatives and clinical-trial infrastructure programs.
She joins Ovid from Vigil Neuroscience—recently acquired by Sanofi—where she served as Chief Medical Officer and oversaw medical, clinical, biomarker, patient advocacy, and regulatory functions.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Ovid Therapeutics Inc Registered Shsmehr Nachrichten
| Keine Nachrichten verfügbar. |
Analysen zu Ovid Therapeutics Inc Registered Shsmehr Analysen
Aktien in diesem Artikel
| Ovid Therapeutics Inc Registered Shs | 1,31 | -10,27% |
|